Redox Regulation by Pitx2 and Pitx3 Is Critical for Fetal Myogenesis

Slides:



Advertisements
Similar presentations
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Advertisements

MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Volume 53, Issue 4, Pages (February 2014)
Volume 55, Issue 1, Pages (July 2014)
Volume 41, Issue 6, Pages (March 2011)
Volume 11, Issue 5, Pages (May 2007)
Volume 138, Issue 2, Pages (February 2010)
Roger B. Deal, Steven Henikoff  Developmental Cell 
Volume 23, Issue 3, Pages (September 2012)
Volume 44, Issue 3, Pages (November 2011)
Volume 26, Issue 4, Pages (August 2013)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 47, Issue 5, Pages e6 (November 2017)
Volume 21, Issue 1, Pages (January 2006)
Volume 23, Issue 3, Pages (February 2013)
Wenqian Hu, Bingbing Yuan, Harvey F. Lodish  Developmental Cell 
Volume 36, Issue 2, Pages (January 2016)
Volume 125, Issue 4, Pages (May 2006)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Volume 41, Issue 4, Pages e5 (May 2017)
Volume 16, Issue 2, Pages (July 2016)
Volume 34, Issue 3, Pages (August 2015)
EB3 Regulates Microtubule Dynamics at the Cell Cortex and Is Required for Myoblast Elongation and Fusion  Anne Straube, Andreas Merdes  Current Biology 
Volume 23, Issue 5, Pages (November 2012)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 47, Issue 3, Pages (August 2012)
Volume 15, Issue 7, Pages (May 2016)
Volume 22, Issue 4, Pages (April 2012)
Volume 14, Issue 5, Pages (May 2008)
Mara Schvarzstein, Andrew M. Spence  Developmental Cell 
Yutian Peng, Lois S. Weisman  Developmental Cell 
Derivation and FACS-Mediated Purification of PAX3+/PAX7+ Skeletal Muscle Precursors from Human Pluripotent Stem Cells  Bianca Borchin, Joseph Chen, Tiziano.
Volume 143, Issue 1, Pages (October 2010)
Volume 33, Issue 1, Pages (April 2015)
Volume 66, Issue 4, Pages e5 (May 2017)
Volume 14, Issue 5, Pages (November 2011)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 30, Issue 4, Pages (May 2008)
HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1  Juli Liu, Yang Li, Bo Lin,
Volume 16, Issue 24, Pages (December 2006)
Volume 27, Issue 8, Pages (April 2017)
Volume 19, Issue 7, Pages (May 2017)
Volume 7, Issue 1, Pages (January 2008)
Ramiro E. Verdun, Laure Crabbe, Candy Haggblom, Jan Karlseder 
Melissa L. Ehlers, Barbara Celona, Brian L. Black  Cell Reports 
Volume 36, Issue 4, Pages (February 2016)
Codependent Activators Direct Myoblast-Specific MyoD Transcription
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 10, Issue 3, Pages (September 2006)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Volume 10, Issue 3, Pages (March 2012)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 130, Issue 2, Pages (July 2007)
Muscle Satellite Cells Are Primed for Myogenesis but Maintain Quiescence with Sequestration of Myf5 mRNA Targeted by microRNA-31 in mRNP Granules  Colin G.
Telomeric Noncoding RNA TERRA Is Induced by Telomere Shortening to Nucleate Telomerase Molecules at Short Telomeres  Emilio Cusanelli, Carmina Angelica Perez.
Xin Xie, Tomas Venit, Nizar Drou, Piergiorgio Percipalle
Volume 18, Issue 8, Pages (February 2017)
Volume 26, Issue 3, Pages (May 2007)
Volume 15, Issue 3, Pages (September 2008)
Volume 9, Issue 9, Pages (May 1999)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Teemu P. Miettinen, Mikael Björklund  Cell Reports 
In Vitro Analysis of Huntingtin-Mediated Transcriptional Repression Reveals Multiple Transcription Factor Targets  Weiguo Zhai, Hyunkyung Jeong, Libin.
Volume 16, Issue 5, Pages (May 2009)
Volume 55, Issue 1, Pages (July 2014)
Volume 11, Issue 3, Pages (March 2010)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 69, Issue 1, Pages e6 (January 2018)
Volume 21, Issue 4, Pages (February 2006)
Yun-Gui Yang, Tomas Lindahl, Deborah E. Barnes  Cell 
Presentation transcript:

Redox Regulation by Pitx2 and Pitx3 Is Critical for Fetal Myogenesis Aurore L’honoré, Pierre-Henri Commère, Jean-François Ouimette, Didier Montarras, Jacques Drouin, Margaret Buckingham  Developmental Cell  Volume 29, Issue 4, Pages 392-405 (May 2014) DOI: 10.1016/j.devcel.2014.04.006 Copyright © 2014 Elsevier Inc. Terms and Conditions

Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Inactivation of Pitx2/3 Leads to Defective Differentiation during Fetal Myogenesis (A and B) Whole-mount in situ hybridization with a probe for Myogenin RNA on (A) control Pitx2flox/flox:Pitx3−/flox:wt and (B) mutant Pitx2flox/flox:Pitx3−/flox:MSD-cre embryos at E13.5 shown in lateral views. Black arrowheads point to differences in expression. The experiments were performed with at least three embryos, and a representative picture of each genotype is shown. (C–K) Coimmunohistochemistry on transverse sections of thoracic somites from (C–E) control Pitx2flox/flox:Pitx3−/flox:wt, (F–H) mutant Pitx2flox/flox:Pitx3−/flox:MSD-cre, and (I–K) mutant Pitx2flox/flox:Pitx3−/flox:HSA-cre embryos at E12.5 costained with the TUNEL reaction (red) and Pax7 (in C, F, and I); myogenin (Myog in D, G, and J), or muscle myosin heavy chain (MF20 in E, H, and K) antibodies. Scale bars, 20 μM. (L) Quantification of the number of TUNEL-positive nuclei that express Pax7, Myogenin (Myog), or muscle Myosin Heavy Chain (MF20), shown as a percentage of the total TUNEL-positive population for mutant Pitx2flox/flox:Pitx3−/flox:MSD-cre embryos at E12.5 (n = 3 embryos, mean ± SD, ∗p < 0.05). Pax7/TUNEL-, Myogenin/TUNEL-, and MF20/TUNEL-positive nuclei were counted and expressed as a percentage of the total TUNEL-positive population. (M) Quantification of the percentage of nuclei that are TUNEL positive for control Pitx2flox/flox:Pitx3−/flox:wt (:wt), mutant Pitx2flox/flox:Pitx3−/flox:MSD-cre (:MSD) and mutant Pitx2flox/floc:Pitx3−/flox:HSA-cre (:HSA) embryos at E12.5 (n = 3 embryos for each genotype; mean ± SD, ∗p < 0.05). (N–P) Sagittal sections at shoulder level of E16.5 (N) control Pitx2flox/flox:Pitx3−/flox:wt, (O) mutant Pitx2flox/flox:Pitx3−/flox:MSD-cre, and (P) mutant Pitx2flox/flox:Pitx3−/flox:HSA-cre embryos stained for TUNEL activity. Open arrowheads point to examples of TUNEL-positive cells. Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Ex Vivo Inactivation of Pitx2/3 Leads to Defective Differentiation due to Apoptosis of Differentiating Myoblasts (A–C) GFP-positive cells, isolated from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were cultured (A) for 120 hr and (B) for 72 hr and 96 hr and in the presence or absence (Ctrl) of 0.5 μM 4-OHT. Cells were stained with DAPI and by immunocytochemistry with Myogenin (green) antibody at 72 hr and 96 hr in (B) and with Troponin T (TnT, red) antibody at 120 hr, with phase contrast images on the left in (A). Scale bars, 20 μM. (C) Results were quantified by counting positive and negative nuclei for each marker. Data represent the mean number of nuclei counted in more than 10 areas per plate for cultures from three embryos under each condition. t, time. (D) GFP-positive cells, isolated as described in (A) through (C), were cultured in the presence or absence (Ctrl) of 0.5 μM 4-OHT. After 96 hr of culture, transcripts, as indicated, were analyzed by qPCR, shown relative to Gapdh transcripts, and standardized to the control as one. nd, not detectable. (E–G) GFP-positive cells, isolated as for (A), were cultured in the presence or absence (Ctrl) of 0.5 μM 4-OHT added at the beginning of the culture (for 4-OHT) or after 72 hr (4-OHT72) and processed for TUNEL staining at the times indicated. (E) TUNEL staining (green) of DAPI-treated cells after 96 hr of culture. White arrowheads point to TUNEL-positive cells. Scale bars, 20 μM. (F) Quantification of the percentage of TUNEL-positive cells at each time point. (G) After 96 hr of culture, qPCR of p53 and Noxa transcripts. In (C), (D), (F), and (G), n = 3 embryos; mean ± SD, ∗p < 0.05. Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Pitx2/3 Mutant Cells Accumulate Abnormal Levels of ROS, Leading to Apoptosis and Impaired Terminal Differentiation (A) Mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+, and control Pitx2flox/+:Pitx3−/+:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were obtained by 4-OHT intraperitoneal injection of pregnant mothers at E8.5 and used for isolation by flow cytometry of two populations, Pax3GFP-High and Pax3GFP-Low, based on their level of expression of GFP. Immediately after purification, cells were incubated with Cell Rox and analyzed by flow cytometry to measure GFP and Cell Rox fluorescence intensity. (B) The whole GFP-positive cell population (High and Low), isolated from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, was cultured for 72 hr in the presence of 0.5 μM 4-OHT, incubated with Cell Rox, trypsinized, and analyzed by flow cytometry to measure fluorescence intensity. As a control, Pitx2/3 mutant cells (+4-OHT) were treated with the antioxidant NAC (10 mM) for 3 hr before Cell Rox incubation. (C) GFP-positive cells, isolated from control Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26R+/+ and inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, were cultured for 72 hr in the presence of 0.5 μM 4-OHT, incubated with Cell Rox, and analyzed by fluorescence microscopy. Scale bars, 5 μM. (D–F) In (D), GFP-positive cells, isolated as in (B), were cultured in the presence or absence (Ctrl) of 0.5 μM 4-OHT. After 48 hr and 72 hr of culture, cells were stained with DAPI and analyzed by immunocytochemistry using Myogenin and γH2AX antibodies. Scale bars in (D) represent 20 μM. (E) γH2AX-positive cells were counted at 48 hr and 72 hr in control and mutant cultures, represented as the percentage of total cells. (F) Myogenin-positive cells were counted and quantified as the percentage of total γH2AX-positive cells in the mutant (4-OHT) population at 72 hr (n = 3 embryos; mean ± SD, ∗p < 0.05). Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Rescue of the Differentiation Defect of Pitx2/3 Mutant Cells by Use of Antioxidants (A–C) GFP-positive cells, isolated from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, were cultured in the presence (4-OHT) or absence (Ctrl) of 0.5 μM 4-OHT. Cells were either cultured under 20% O2 (Ctrl and 4-OHT) or 3% O2 (4-OHT 3% O2) for 96 hr and 120 hr and processed for (A) TUNEL staining and (B) Troponin T (TnT) staining or (C) incubated with Cell Rox, trypsinized, and analyzed by flow cytometry to measure fluorescence intensity. (A) TUNEL-positive cells or (B) Troponin T-positive cells were counted and quantified as the percentage of total cells. ROS levels are expressed as absolute units (A.U.) (n = 3 embryos; mean ± SD, ∗p < 0.05). (D–H) GFP-positive cells, isolated from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, were cultured in the presence of 0.5 μM 4-OHT with or without 5 mM NAC (added at t0). Cells were cultured either under 20% O2 (Ctrl and 4-OHT) or 3% O2 (4-OHT, 3% O2; 4-OHT + NAC, 3% O2). Cells were visualized under phase contrast after 120 hr of culture, as shown in (D), or analyzed by immunocytochemistry with Myogenin, Troponin T, and γH2AX antibodies and by the TUNEL reaction after 72 hr or 96 hr of culture, as shown in (E) through (H). In (E), immunofluorescence on DAPI-stained cells with a Myogenin antibody after 96 hr of culture is shown. In (F) through (H), Myogenin-, Troponin T-, γH2AX-, and TUNEL-positive cells were counted and quantified as the percentage of total cells (n = 4 embryos; mean ± SD, ∗p < 0.05). Scale bars, 20 μM. Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 5 Pitx2/3 Directly Regulate Transcription Factors and Enzymes that Protect against Oxidative Damage (A) Two populations, Pax3GFP-High and Pax3GFP-Low, were isolated by flow cytometry from Pax3GFP/+ embryos at E13.5 based on their level of expression of GFP. RNA samples were analyzed by qPCR for transcripts of proliferation markers, myogenic transcription factors, antioxidant enzymes and transcription factors, and mitochondrial and metabolic genes, relative to the level of Gapdh transcripts. The data are represented as a heat map. (B) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos were cultured in the presence (4-OHT) or absence (Ctrl) of 0.5 μM 4-OHT. After 72 hr of culture, samples were analyzed by qPCR for transcripts of antioxidant transcription factors and enzymes relative to Gapdh transcripts in mutant/control cells, expressed as a log ratio (n = 3 embryos; mean ± SD, ∗p < 0.05). (C and D) Mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCre-ERT2/+ and control Pitx2flox/+:Pitx3−/+:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were obtained by 4-OHT intraperitoneal injection of pregnant mothers at E8.5 and used for isolation by flow cytometry of the Pax3GFP-Low population. (C) RNA was analyzed by qPCR for antioxidant enzyme transcripts relative to Gapdh transcripts in control/mutant (Ctrl/Mut) cells, expressed as a log ratio (n = 2 embryos; mean ± SD, ∗p < 0.05). (D) GFP-positive cells isolated from Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos were cultured for 72 hr in the presence (+4-OHT) or absence (Ctrl) of 0.5 μM 4-OHT and processed for protein extraction. Western blot analysis indicated the level of Pitx2, Pitx3, Nrf1, SOD1, Mt1, Gsta1, and Aldh1a1 proteins. The experiments were performed with three independent cultures, and a representative experiment is shown. (E) Antioxidant total capacity was measured (n = 3 embryos; mean ± SD, ∗p < 0.05). (F) ChIP analysis for the presence of Pitx2/3 on Nrf1 regulatory sequences (black) and negative control regions (gray), as indicated, was performed on chromatin isolated from the trunk and limbs of wild-type embryos at E13.5. The location of PitxREs, histone marks for active chromatin and RNA polymerase II (Pol II) binding, is indicated for the Nrf1 gene on the right. (G) Activation of the Nrf1 promoter by Pitx2 and Pitx3. 293 cells were transfected with a luciferase reporter construct containing Nrf1 regulatory sequences (Nrf1-wt-luc). Dose response is shown for cotransfection of increasing amounts of Pitx2 and Pitx3 expression plasmids. Mutations of both PitxRE prevented transactivation (n = 3 independent experiments, each performed in duplicate, mean ± SD, ∗p < 0.05). (H) ChIP analysis for the presence of Pitx2/3 and Nrf1 on Mt1, Aldh1a1, SOD1, and Gsta1 regulatory sequences was carried out on chromatin prepared from the trunk and limbs of wild-type embryos at E13.5. The y axis shows the average percentage of immunoprecipitation compared to input for regulatory regions of each gene (black) or negative control regions (gray) located close to each gene. Results presented are the average ± SD of three different ChIP experiments performed on three independent chromatin preparations, ∗p < 0.05. (I) Scheme for proposed targets of Pitx2/3 and Nrf1. Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 6 Pitx2/3 Mutant Cells Are Characterized by Impaired Mitochondrial Function at the Onset of Differentiation (A–C) GFP-positive cells from Pax3GFP/+ embryos at E13.5 were separated by flow cytometry and cultured. (A) Cells were transfected 24 hr after plating with siRNA directed against SOD1, Gst1a, and Mt1 transcripts or with siControl. As a positive control, GFP-positive cells from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos at E13.5 were separated by flow cytometry and cultured in the presence of 4-OHT without any transfection. After 96 hr of culture, cells were (B) processed for quantification of ROS content with Cell Rox, expressed as absolute units (A.U.), or (C) analyzed by immunocytochemistry using the TUNEL reaction. TUNEL-positive cells were counted and quantified as the percentage of total cells (n = 3 independent transfections, each performed in duplicate; mean ± SD, ∗p < 0.05). (D and E) Mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ and control Pitx2flox/+:Pitx3−/+:Pax3GFP/+:R26RCRE-ERT2/+ embryos at E13.5 were obtained by 4-OHT intraperitoneal injection of pregnant mothers at E8.5 and used for isolation by flow cytometry of the Pax3GFP-Low population. (D) RNA was analyzed by qPCR for transcripts of Tfam and respiratory chain components relative to Gapdh transcripts in mutant (mut) /control (ctrl) cells, expressed as a log ratio (n = 2 embryos; mean ± SD, ∗p < 0.05). (E) Pax3GFP-Low cells were used after purification for quantification of the NAD+/NADH ratio (n = 2 embryos; mean ± SD, ∗p < 0.05). (F and G) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos were cultured in the presence (4-OHT) or absence (Ctrl) of 0.5 μM 4-OHT. After 72 hr of culture, samples were processed for (F) quantification of ATP content and (G) mitochondrial ROS levels expressed as absolute units (A.U.) (n = 3 embryos for each gene; mean ± SD, ∗p < 0.05). (H–J) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos were cultured in the presence of 0.5 μM 4-OHT. After 24 hr of culture, cells were transfected with siRNA directed against Tfam transcripts or siControl. Cells were processed for immunohistochemistry using (I) Myogenin antibodies or (J) TUNEL staining at 96 hr. (I) Results were quantified by counting positive and negative nuclei. Data represent the mean number of nuclei counted in more than 10 areas per plate for cultures from three independent transfections. (J) TUNEL-positive cells were counted and quantified as the percentage of total cells (n = 3 embryos; mean ± SD, ∗p < 0.05). Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 7 Rescue of the Differentiation Defect of Pitx2/3 Mutant Cells by Nrf1 Expression (A–C) GFP-positive cells from inducible mutant Pitx2flox/flox:Pitx3−/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos at E13.5 were separated by flow cytometry and cultured in the presence (4-OHT) or absence (Ctrl) of 0.5 μM 4-OHT. Fourteen hours after plating, cells were infected with lentiviral particles expressing the red fluorescent protein (RFP) reporter gene alone or Nrf1 with the reporter RFP (RFP-Nrf1). (A) After 120 hr of culture, control and mutant cells were stained with DAPI and analyzed by immunocytochemistry using RFP (red) and Troponin T (green) antibodies. (B) RFP- and Troponin T-double-positive cells were counted and quantified as a percentage of total RFP-positive cells (n = 5 embryos; mean ± SD, ∗p < 0.05). (C) After 72 hr of culture, cells transduced by RFP or RFP-Nrf1 were incubated with Cell Rox, trypsinized, and analyzed by flow cytometry to measure fluorescence intensity. (n = 3 embryos for each gene; mean ± SD, ∗p < 0.05). (D and E) In (D), a model of Pitx2/3 gene function during fetal myogenesis is shown: Pitx2/3 genes prevent excessive oxidative stress during differentiation through the regulation of Nrf1 and genes for antioxidant enzymes. (E) In their absence, differentiating cells accumulate excessive ROS levels due to low expression of antioxidant enzymes and defective mitochondrial respiration, leading to DNA damage and apoptosis. MyHC, myosin heavy chain; TnT, troponin; Mt, mitochondria. Developmental Cell 2014 29, 392-405DOI: (10.1016/j.devcel.2014.04.006) Copyright © 2014 Elsevier Inc. Terms and Conditions